Exodus Point Capital Management, LP Amarin Corp Plcuk Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.85 - $1.43 $2.48 Million - $4.17 Million	-2,917,160 Reduced 74.93%	976,150 $898,000
Q2 2023 Aug 10, 2023	BUY	$1.12 - $1.49 $4.36 Million - $5.8 Million	3,893,310 New	3,893,310 $4.63 Million
Q4 2022 Feb 13, 2023	BUY	$1.07 - $1.34 $434,911 - $544,655	406,459 Added 18.87%	2,560,048 $3.1 Million
Q3 2022 Nov 10, 2022	BUY	$1.09 - $1.67 $2.35 Million - $3.6 Million	2,153,589 New	2,153,589 $2.35 Million
Q4 2021 Feb 11, 2022	SELL	$3.24 - $5.18 $347,340 - $555,316	-107,204 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $422,383 - $626,071	107,204 New	107,204 $547,000
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $647,690 - $1.38 Million	-177,937 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $774,221 - $1.34 Million	161,971 Added 1014.47%	177,937 $1.23 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $31,532 - $169,720	-7,883 Reduced 33.05%	15,966 $64,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $332,455 - $575,237	23,849 New	23,849 $511,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.